Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/2012
03/29/2012US20120076819 Compositions And Methods For Treating of Microbial Infections
03/29/2012US20120076774 Detection and/or treatment of diseases associated with autoantibodies
03/29/2012US20120076770 Modulation of autophagy and and serotonin for treatment of multiple myeloma related diseases
03/29/2012CA2812362A1 Matrix metalloproteinase inhibitors
03/29/2012CA2812361A1 Matrix metalloproteinase inhibitors
03/28/2012EP2433940A1 Spiroimidazolone derivative
03/28/2012EP2432774A2 Compounds, compositions and methods for modulating uric acid levels
03/28/2012EP2432489A2 Variants of c-type natriuretic peptide
03/28/2012EP2432480A1 Compositions and methods for treating inflammatory arthritis
03/28/2012EP1569676B1 Calcitonin drug-oligomer conjugates, and uses thereof
03/28/2012EP1453508B1 Tempamine compositions and use against cellular oxidative damage
03/28/2012EP1283851B1 Use of il-4r antibodies and compositions thereof
03/28/2012EP1117689B1 Bone morphogenetic protein antagonists based on the mature protein
03/28/2012CN1871024B Remedy and therapeutic method for periodontal diseases and pulpal diseases
03/28/2012CN1635901B Remodeling and glycoconjugation of peptides
03/28/2012CN1583063B Extraction of effective components from frankinscene and its preparation and use
03/28/2012CN102395589A Fused pyrrolopyridine derivative
03/28/2012CN102391342A Dexamethasone palmitate compound and preparation method thereof
03/28/2012CN102391335A Isopentene flavonol glycoside derivative and preparation method and application thereof
03/28/2012CN102389552A External medicinal liquor used for treating rheumatic ostalgia
03/28/2012CN102389548A Application of Smilax glabra flavonoid extract in preparing drugs for treating hyperuricemia
03/28/2012CN102389546A Traditional Chinese medicine for curing diabetic metabolic arthritis
03/28/2012CN102389545A Traditional Chinese medicine for treating diabetic gout
03/28/2012CN102389543A Traditional Chinese medicine for curing diabetic metabolic arthritis
03/28/2012CN102389506A Pharmaceutical composition for treating rheumatism and rheumatoid arthritis
03/28/2012CN102389490A Chinese medical ointment matched with meridian moxibustion guide instrument for external application and preparation method thereof
03/28/2012CN102389456A Method for extracting isodon japonica var.galaucocalyx total diterpenoids or Glaucocalyxin A
03/28/2012CN102389440A Application of iridoid in preparation of anti-osteoporosis medicines
03/28/2012CN102389411A Application of gallic acid to preparation of phosphodiesterase inhibitor anti inflammatory medicine
03/28/2012CN102389405A Tripterine oral self-emulsification dispersible tablet and its preparation method
03/28/2012CN102133380B Medicament for treating cervical spondylosis
03/28/2012CN102028901B Traditional Chinese medicine for treating knee joint hypertrophic synovitis
03/28/2012CN102028887B Traditional Chinese medicine for treating hyperplasia of cervical vertebra
03/28/2012CN102028757B Processing method of mulberry composite extract
03/28/2012CN102018736B Natural indigo decoction piece and preparation method thereof
03/28/2012CN102000235B Externally-applied health-care medicinal wine
03/28/2012CN101973925B 2-indolone compound with anti-inflammatory activity, preparation method and medicinal application thereof
03/28/2012CN101912386B Application of quercetin dimer flavone for preparing anti-oxidation medicines
03/28/2012CN101690788B Throat-clearing three dispersion granules
03/28/2012CN101643488B Extraction purification process of teasel root saponin
03/28/2012CN101188949B Egg-derived bone-strengthening composition
03/28/2012CN101139361B Targeting osteoporosis-resistant drug and preparation method thereof
03/27/2012US8143486 Delta-5 desaturase and uses thereof
03/27/2012US8143383 Δ-6 desaturase and uses thereof
03/27/2012US8143297 Heterocyclic derivatives as modulators of ion channels
03/27/2012US8143261 Thiazolo (4,5-D) pyrimidine compounds
03/27/2012US8142778 Methods of treatment using CTLA-4 antibodies
03/27/2012US8142773 Isolating progenitor cell tissue via antibody specific binding, transfering into recipient host, monitor cell propagation; tissue engineering; regenerative medicine
03/27/2012CA2603671C Insp163 polypeptides for the treatment or prevention of cancer and arthritis
03/27/2012CA2489862C Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
03/27/2012CA2470245C Ifnar2 mutants, their production and use
03/27/2012CA2329250C Peptide antiangiogenic drugs
03/22/2012WO2012037083A2 Compositions and method for promoting musculoskeletal repair
03/22/2012WO2012037043A2 Treatment of autoimmune inflammation using mir-155
03/22/2012WO2012036512A2 Use of a compound for inducing differentiation of mesenchymal stem cells into cartilage cells
03/22/2012WO2012036233A1 Condensed heterocyclic derivative having melanine-concentrating hormone receptor antagonistic activity
03/22/2012WO2012035904A1 Agent for promoting hyaluronic acid production
03/22/2012WO2012035770A1 Osteogenesis promoting agent containing glycogen
03/22/2012WO2012035685A1 Composition for promoting hyaluronic acid production
03/22/2012WO2011136585A3 Composition for treating bone disease comprising a glyceollin as an active ingredient
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071653 Human Adam-10 Inhibitors
03/22/2012US20120071547 Compounds from soft coral, method of preparation and pharmaceutical uses thereof
03/22/2012US20120071535 Estrogen receptor modulators and uses thereof
03/22/2012US20120071534 Lxr modulators
03/22/2012US20120071477 Cdki pathway inhibitors and uses thereof
03/22/2012US20120071460 Pyrazole oxadiazole derivatives as s1p1 agonists
03/22/2012US20120071450 Organic compounds
03/22/2012US20120071446 Dosage regimen of an s1p receptor agonist
03/22/2012US20120071439 Cartilage production promoter and prophylactic or therapeutic agent for diseases associated with cartilage damage
03/22/2012US20120071431 Platycodin Radix Extracts, and Their Use in Treating Disease Conditions Associated with Angiogenesis
03/22/2012US20120071414 Method for producing and using active principles of limestone
03/22/2012US20120071399 Sulfation of wnt pathway proteins
03/22/2012US20120071394 Novel polypeptides and use thereof
03/22/2012US20120070521 Method of extraction from withania somnifera and one or more fractions containing pharmacologically active ingredients obtained therefrom
03/22/2012US20120070519 Method for extraction of fractions containing pharmacologically active ingredients with less cytotoxicity from one or more plants
03/22/2012US20120070512 Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives
03/22/2012US20120070506 Animal Treatment
03/22/2012US20120070503 Nanoparticle-Based Targeted Drug Delivery For In Vivo Bone Loss Mitigation
03/22/2012US20120070492 Rhein or diacerein compositions
03/22/2012US20120070466 Conjugated Polymeric Material and Uses Thereof
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/22/2012US20120070436 Antigen-binding proteins
03/22/2012US20120070418 Stem cells for musculoskeletal tissue repair
03/22/2012US20120070372 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
03/22/2012US20120070370 Spiro 1,3,4-thiadiazoline derivatives as ksp inhibitors
03/22/2012US20120070369 Hif inhibitors and use thereof
03/22/2012DE102010046218A1 Device, useful for treatment of injuries and illnesses of e.g. tendons and ligaments, comprises a layer system with at least three layers respectively comprising identical or different, dimensionally stable and biocompatible hydrogel
03/21/2012EP2431365A1 Azetidine compound and medicinal use thereof
03/21/2012EP2431361A1 Ascorbic acid aryl acetate/propionate ester, preparation method and pharmaceutical composition thereof
03/21/2012EP2430048A1 Blocking anti-dkk-1 antibodies and their uses
03/21/2012EP2429987A2 Amide compound, preparation method thereof and pharmaceutical composition comprising same
03/21/2012EP2429533A1 Sulphated hyaluronic acids as regulator agents of the cytokine activity
03/21/2012EP2429508A1 Lycopene and resveratrol dietary supplement
03/21/2012EP1670766B1 Bicyclic imino acid derivatives for the treatment of (inter alia) diseases relating to the locomotor system
03/21/2012EP1534248B1 Lasofoxifene tablet and its coating
03/21/2012EP1439174B1 4-IMIDAZOLIN-2-ONE COMPOUNDS AS p38 MAP KINASE INHIBITORS
03/21/2012EP1404412B1 Protein C for wound healing
03/21/2012EP1387854B1 Sfrp and peptide motifs that interact with sfrp and methods of their use
03/21/2012CN1441770B Modified forms of pharmacologically active agents and uses therefor
1 ... 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 ... 820